epigallocatechin gallate
Pre-clinical- Indications
- Low-grade cervical intraepithelial neoplasia
Company intelligence / Profile preview
Amplexd Therapeutics
Gaithersburg, Maryland, United Statesamplexd.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Amplexd has completed promising preclinical studies for two non-invasive therapies for CIN treatment and secured $2 million in funding to finalize development and IND submissions ahead of first-in-human clinical trials[1][2][3]
- Therapeutic areas
- OncologyWomen's Health
- Modalities
- Topical therapiesPhotodynamic therapy (PDT)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Amplexd Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Amplexd Therapeutics.